Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Peak Pharmaceuticals	Williston	Tower One Wireless	Acura Pharmaceuticals	BetterLife Pharma
Symbol	OTCMKTS:PKPH	OTCMKTS:WHCA	OTCMKTS:TOWTF	OTCMKTS:ACUR	OTCMKTS:BETRF
Price Information
Current Price	$0.11	$0.70	$0.10	$0.38	$0.49
52 Week Range	N/A	N/A	N/A	N/A	N/A
MarketRank™
Overall Score	0.7	0.0	0.0	0.6	0.0
Analysis Score	0.0	0.0	0.0	0.0	0.0
Community Score	3.7	0.0	0.0	2.8	0.0
Dividend Score	0.0	0.0	0.0	0.0	0.0
Ownership Score	0.0	0.0	0.0	0.0	0.0
Earnings & Valuation Score	0.0	0.0	0.0	0.0	0.0
Analyst Ratings
Consensus Recommendation	N/A	N/A	N/A	N/A	N/A
Consensus Price Target	N/A	N/A	N/A	N/A	N/A
% Upside from Price Target	N/A	N/A	N/A	N/A	N/A
Trade Information
Market Cap	$8.51 million	$9.51 million	$9.33 million	$8.40 million	$8.46 million
Beta	0.46	-1.09	0.2	0.79	3.8
Average Volume	370,884	720	113,582	15,535	77,276
Sales & Book Value
Annual Revenue	N/A	N/A	$4.08 million	$2.66 million	N/A
Price / Sales	N/A	N/A	2.29	3.16	N/A
Cashflow	N/A	N/A	N/A	N/A	N/A
Price / Cash	N/A	N/A	N/A	N/A	N/A
Book Value	N/A	N/A	($0.07) per share	($0.22) per share	$0.12 per share
Price / Book	N/A	N/A	-1.43	-1.73	N/A
Profitability
Net Income	N/A	N/A	$-3,750,000.00	N/A	$-14,780,000.00
EPS	N/A	N/A	N/A	N/A	N/A
Trailing P/E Ratio	0.00	0.00	N/A	N/A	N/A
Forward P/E Ratio	∞	∞	∞	∞	∞
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	N/A	N/A	N/A	-19.89%	N/A
Return on Equity (ROE)	N/A	N/A	N/A	-1.36%	-734.15%
Return on Assets (ROA)	N/A	N/A	-39.36%	-34.83%	-219.66%
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	0.08%	1.37%	0.16%
Quick Ratio	N/A	N/A	0.08%	1.37%	0.16%
Ownership Information
Institutional Ownership Percentage	N/A	N/A	N/A	N/A	N/A
Insider Ownership Percentage	N/A	N/A	N/A	5.60%	34.77%
Miscellaneous
Employees	1	N/A	N/A	12	7
Shares Outstanding	78.36 million	13.58 million	93.34 million	22.11 million	17.21 million
Next Earnings Date	N/A	N/A	7/13/2021 (Estimated)	7/5/2021 (Estimated)	7/5/2021 (Estimated)
Optionable	Not Optionable	Not Optionable	Not Optionable	Not Optionable	Not Optionable

Source	Headline
	BetterLife Pharma files patent protection for an implant designed to mitigate excess psychedelic dosage effects proactiveinvestors.com - May 1 at 10:07 AM
	BetterLife files patent for implant to prevent drug diversion of LSD and other psychedelic drugs canadianinvestor.com - April 29 at 3:31 PM
	BetterLife Files Patent for Invention of Novel Subcutaneous Implant to Prevent Drug Diversion of LSD and Other Psychedelic Drugs finance.yahoo.com - April 29 at 10:31 AM
	April Psychedelic Capital Investigates Clinical Trials & Real World Evidence & Going Mainstream: Mass Adoption finance.yahoo.com - April 28 at 12:58 PM
	Short Interest in BetterLife Pharma Inc. (OTCMKTS:BETRF) Declines By 94.8% americanbankingnews.com - April 28 at 1:00 AM
	Former FDA Psychiatry Division Director Dr. Thomas Laughren Joins BetterLife as Regulatory Advisor finance.yahoo.com - April 8 at 12:27 PM
	BetterLife Added to Horizons Psychedelic Stock Index ETF finance.yahoo.com - March 29 at 9:31 AM
	BetterLife Pharma says subsidiary Altum Pharmaceuticals to conduct coronavirus trial in Chile using its AP-003 proactiveinvestors.com - March 26 at 8:56 PM
	BetterLife Pharma inks research agreement with the University of California San Diego proactiveinvestors.com - March 26 at 8:56 PM
	BetterLife Pharma: BetterLife Enters Into Research Agreement with UCSD for TD-0148A Behavioural Pharmacology Studies finanznachrichten.de - March 24 at 12:53 PM
	BetterLife Enters Into Research Agreement with UCSD for TD-0148A Behavioural Pharmacology Studies finance.yahoo.com - March 24 at 12:53 PM
	BetterLife Subsidiary, Altum Pharmaceuticals, to Conduct Randomized Placebo-controlled COVID-19 Trial Using AP-003 finance.yahoo.com - March 11 at 12:21 PM
	BetterLife Pharma announces tie-up with Carleton University to study TD-0148A as treatment for depression proactiveinvestors.com - March 10 at 8:32 AM
	BetterLife Enters Research Agreement with Carleton University for TD-0148A Depression Studies finance.yahoo.com - March 8 at 8:09 AM
	Proactive news headlines including BetterLife Pharma, HempFusion Wellness, Pure Gold Mining, apnews.com - March 5 at 12:24 AM
	BetterLife engages Eurofins CDMO for psychedelic TD-0148A manufacturing canadianinvestor.com - March 3 at 7:51 PM
	BetterLife Pharma hires Eurofins CDMO to manufacture LSD derivative TD-0148A proactiveinvestors.com - March 3 at 2:50 PM
	BetterLife Engages Eurofins CDMO for Next Generation Psychedelic TD-0148A Manufacturing finance.yahoo.com - March 3 at 9:50 AM
	BetterLife Pharma files patent protection for its newest compound TD-010 to treat anxiolytic-use disorder proactiveinvestors.com - February 2 at 12:29 PM
	BetterLife Files Patent Protection on Dihydrohonokiol-B for Treatment of Anxiolytic Use Disorder finance.yahoo.com - February 2 at 12:29 PM
	BetterLife Pharma inhaled coronavirus treatment passes six months of cold temperature tests proactiveinvestors.com - January 28 at 8:16 PM
	BetterLife Pharma partners with Eurofins Discovery for pharmacology studies of Eurofins' LSD-derived molecule TD-0148A proactiveinvestors.com - January 28 at 10:15 AM
	BetterLife Engages Eurofins Discovery for its Next Generation Psychedelics 2-bromo-LSD FDA ... apnews.com - January 28 at 5:15 AM
	BetterLife Demonstrates 6 months Refrigerated Stability of its Proprietary Interferon ... apnews.com - January 26 at 11:23 AM
	BetterLife Demonstrates 6 months Refrigerated Stability of its Proprietary Interferon Formulation to be Developed to Treat Early Stage Covid-19 Cases benzinga.com - January 26 at 11:23 AM

Date	Company	Brokerage	Action

(Data available from 5/13/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources